Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 12, 2009, Pages 2701-2703

  Nastro, Enrico ^a   Allegra, Alessandro ^a   Oteri, Giacomo ^a   Ferlito, Sebastiano ^a   Alonci, Andrea ^a   Bellomo, Giacomo ^a   D'Angelo, Arianna ^a   Tolomeo, Annamaria ^a   Cicciù, Domenico ^a   De Ponte, Francesco Saverio ^a   Musolino, Caterina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; BISPHOSPHONIC ACID DERIVATIVE; DAUNORUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AVASCULAR NECROSIS; BONE METASTASIS; CANCER CHEMOTHERAPY; DISEASE ASSOCIATION; HUMAN; JAW OSTEONECROSIS; LETTER; LEUKEMIA; LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; SURGICAL TECHNIQUE;

ADULT; ANTINEOPLASTIC AGENTS; DIPHOSPHONATES; GLUCOCORTICOIDS; HUMANS; JAW DISEASES; MALE; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 71549121020     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.05.369     Document Type: Letter

References (10)

1. Arico M., Boccalatte M.F., Silvestri D., et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88 (2003) 747
2. Ribeiro R.C., Fletcher B.D., Kennedy W., et al. Magnetic resonance imaging detection of avascular necrosis of bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 15 (2001) 891
3. Strauss A.J., Su J.T., Dalton V.M.K., et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 19 (2001) 3066
4. Nastro E., Musolino C., Allegra A., et al. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. Acta Haematol 117 (2006) 181
5. Relling M., Yang W., Das S., et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 22 (2004) 3930
6. Allegra A., Oteri G., Nastro E., et al. Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells. Hematol Oncol 25 (2007) 164
7. Alonci A., Allegra A., Bellomo G., et al. Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified soluble vascular endothelial growth factor receptor 1. Leuk Lymph 48 (2007) 1852
8. Hernigou P., and Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res (2002) 14
9. Gangji V., Hauzeur J.P., Matos C., et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86 (2004) 1153
10. Katsube K., Bishop A.T., Simari R.D., et al. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J Orthop Res 23 (2005) 469